ANIK vs SHW · rev $62.2M vs P/E 29, rev $12.46B
Anika Therapeutics Inc (ANIK) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Latest reported ANIK revenue for 2026-06-30 was $62.2M. Net income was -$1.7M. ANIK currently screens at market cap $161.3M.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
ANIK currently screens at market cap $161.3M. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the ANIK and SHW stock pages for the full models.
Not investment advice.